Long Term Survival Analysis of Hepatectomy for Neuroendocrine Tumour Liver Metastases

Table 1

Demographic data of patients before hepatectomy.

Variables	(𝑛=12)
Sex (M : F)	7 : 5
Age (median (range))-liver resection	48.5 (20–71)
HBsAg positive	2 (16.7%)
Serum bilirubin level (umol/L)	8.5 (4–22)
Serum AST	30 (17–203)
Serum ALT	28 (16–65)
INR	1 (0.9–1.2)
Albumin (g/L)	41 (35–46)
PT (second)	12.1 (10.2–14.9)
Creatinine level (umol/L)	80 (58–131)
Hemoglobin level (g/dL)	12.6 (9.3–14.9)
No. of patients with comorbid disease(s)	5 (41.7%)
(i) Cardiovascular disease	9 (75%)
(ii) Pulmonary disease	1 (8.3%)
(iii) Renal impairment	0 (0%)
(iv) Diabetes mellitus	2 (16.7%)
(v) Grave disease	1 (8.3%)